BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31114991)

  • 1. LncRNA SNHG14 promotes the development of cervical cancer and predicts poor prognosis.
    Zhang YY; Li M; Xu YD; Shang J
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3664-3671. PubMed ID: 31114991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA SNHG14 promotes proliferation of endometrial cancer through regulating microRNA-655-3p.
    Wang GF; Wen LN
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10410-10418. PubMed ID: 33155197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher lncRNA CASC15 expression predicts poor prognosis and associates with tumor growth in cervical cancer.
    Shan S; Li HF; Yang XY; Guo S; Guo Y; Chu L; Xu MJ; Xin DM
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):507-512. PubMed ID: 30720157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA SNHG14 promotes the progression of cervical cancer by regulating miR-206/YWHAZ.
    Ji N; Wang Y; Bao G; Yan J; Ji S
    Pathol Res Pract; 2019 Apr; 215(4):668-675. PubMed ID: 30611620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA GClnc1 promotes progression of colorectal cancer by inhibiting p53 signaling pathway.
    Dong YX; Pang ZG; Zhang JC; Hu JQ; Wang LY
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5705-5713. PubMed ID: 31298323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA SNHG14 potentiates pancreatic cancer progression via modulation of annexin A2 expression by acting as a competing endogenous RNA for miR-613.
    Deng PC; Chen WB; Cai HH; An Y; Wu XQ; Chen XM; Sun DL; Yang Y; Shi LQ; Yang Y
    J Cell Mol Med; 2019 Nov; 23(11):7222-7232. PubMed ID: 31513352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncSNHG14 promotes ovarian cancer by targeting microRNA-125a-5p.
    Zhao YL; Huang YM
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3235-3242. PubMed ID: 31081075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Expression Levels of Long Non-Coding RNA, Loc554202, Are Predictive of Poor Prognosis in Cervical Cancer.
    Chen J; Zhu J
    Tohoku J Exp Med; 2017 Nov; 243(3):165-172. PubMed ID: 29129878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer.
    Cao S; Liu W; Li F; Zhao W; Qin C
    Int J Clin Exp Pathol; 2014; 7(10):6776-83. PubMed ID: 25400758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of LncRNA PANDAR predicts poor prognosis and promotes cell proliferation in cervical cancer.
    Huang HW; Xie H; Ma X; Zhao F; Gao Y
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4529-4535. PubMed ID: 29131264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA XLOC_006390 promotes cervical cancer proliferation and metastasis through the regulation of SET domain containing 8.
    Luan X; Wang Y
    Oncol Rep; 2017 Jul; 38(1):159-166. PubMed ID: 28534991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Noncoding RNA TP73-AS1 Targets MicroRNA-329-3p to Regulate Expression of the SMAD2 Gene in Human Cervical Cancer Tissue and Cell Lines.
    Guan MM; Rao QX; Huang ML; Wang LJ; Lin SD; Chen Q; Liu CH
    Med Sci Monit; 2019 Oct; 25():8131-8141. PubMed ID: 31663517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
    Xu C; Cui H; Li H; Wu Y; An H; Guo C
    J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of long non-coding RNA LINC00518 inhibits cervical cancer proliferation and metastasis by modulating JAK/STAT3 signaling.
    Wang DW; You D; Dong J; Liu TF
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):496-506. PubMed ID: 30720156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
    Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA SNHG14 enhances migration and invasion of ovarian cancer by upregulating DGCR8.
    Zhao JL; Wang CL; Liu YL; Zhang GY
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10226-10233. PubMed ID: 31841176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA 00152 promotes cell proliferation in cervical cancer via regulating miR-216b-5p/HOXA1 axis.
    Zheng JJ; Du XJ; Wang HP; Zhou LY; Wang YJ; Zhang L; Xu H; Zhang J; Hu ZF
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3654-3663. PubMed ID: 31114990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of Long Non-Coding RNA CCAT2 in Cervical Cancer Cell Growth and Apoptosis.
    Wu L; Jin L; Zhang W; Zhang L
    Med Sci Monit; 2016 Mar; 22():875-9. PubMed ID: 26983975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of long non-coding RNA CCAT2 correlates with tumor metastasis and poor prognosis in cervical squamous cell cancer patients.
    Chen X; Liu L; Zhu W
    Int J Clin Exp Pathol; 2015; 8(10):13261-6. PubMed ID: 26722527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
    Wei L; Qin XP; Zhao XX; Wang W
    Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.